SMFM Clinical Practice Guidelines

Slides:



Advertisements
Similar presentations
Evidence-based Public Health Interventions Robert S. Lawrence, MD Bloomberg School of Public Health Johns Hopkins University April 20, 2005.
Advertisements

What is Evidence Based Dentistry Author: Gökhan Alpaslan DMD,Ph.D
UOG Journal Club: September 2012 Perinatal outcome in women treated with progesterone for the prevention of preterm birth: a meta-analysis Sotiriadis A,
HOW EVIDENCE AND EVIDENCE-BASED CLINICAL GUIDELINES HELP CAREGIVERS SUPPORT TREATMENT "Do Carers Care About Research? Laura (Collins) Lyster-Mensh, Executive.
Utilizing Evidence Based Practice in the Acute Care Clinical Setting Brenda P. Johnson, PhD, RN Department of Nursing Southeast Missouri State University.
Clinical Policy / Practice Guideline Development Andy Jagoda, MD, FACEP Professor of Emergency Medicine Mount Sinai School of Medicine New York, New York.
NCCN and NCCN Clinical Practice Guidelines in Oncology™
Chapter 7. Getting Closer: Grading the Literature and Evaluating the Strength of the Evidence.
By Dr. Ahmed Mostafa Assist. Prof. of anesthesia & I.C.U. Evidence-based medicine.
Introduction to evidence based medicine
Anticoagulant therapy in RPL Dr. Z. Heidar Assistant professor SBMU.
Critical Appraisal of Clinical Practice Guidelines
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
SMFM Clinical Practice Guidelines Doppler assessment of the fetus with intrauterine growth restriction Society of Maternal Fetal Medicine with the Assistance.
Evidence-Based Medicine in Clinical Practice.
MULTIPLE PREGNANCY King Khalid University Hospital Department of Obstetrics & Gynecology Course 482.
SMFM Clinical Practice Guidelines
SMFM Clinical Practice Guidelines Activity Restriction in Pregnancy Society of Maternal Fetal Medicine with the assistance of Erin Habecker, MD, and Anthony.
Evidence Based Medicine
Brief summary of the GRADE framework Holger Schünemann, MD, PhD Chair and Professor, Department of Clinical Epidemiology & Biostatistics Professor of Medicine.
SMFM/ACOG Obstetric Care Consensus
SMFM Clinical Practice Guidelines Assessing nutritional needs in pregnant patients with prior bariatric surgery Society of Maternal Fetal Medicine with.
SMFM Consult Series The importance of determining chorionicity in twin gestations Society of Maternal Fetal Medicine with the assistance of Kenneth J.
Evidence-Based Public Health Nancy Allee, MLS, MPH University of Michigan November 6, 2004.
A. R. Markos FRCOG FRCP Consultant in Genito Urinary Medicine and Sexual Health Mid Staffordshire NHS Foundation Trust Stafford, UK.
Evidence-Based Practice: Evidence-Based Practice: NUR 126 Denise Filiatrault Adopted from Curry College Division of Nursing Elizabeth Kudzma.
STRATEGIES FOR PREVENTION OF CVC INFECTIONS 1) Is chlorhexidine a more effective cutaneous antiseptic agent than povidone-iodine for CVC insertion and.
VANDERBILT EVIDENCE-BASED PRACTICE CENTER Katherine E. Hartmann, MD, PhD Lucius E. Burch Chair, Obstetrics and Gynecology Deputy Director, Institute for.
Evidence-Based Medicine Presentation [Insert your name here] [Insert your designation here] [Insert your institutional affiliation here] Department of.
SMFM Clinical Practice Guidelines Isolated fetal choroid plexus cysts Society of Maternal Fetal Medicine with the assistance of Karin M. Fuchs MD Published.
Historical perspective It all started with Aspirin….
SMFM Clinical Practice Guidelines Tdap Vaccination in pregnancy Society of Maternal Fetal Medicine with the assistance of Neil Silverman, MD Published.
RevMan for Registrars Paul Glue, Psychological Medicine What is EBM? What is EBM? Different approaches/tools Different approaches/tools Systematic reviews.
SMFM Consult Series Advanced maternal age and the risk of antepartum stillbirth Society of Maternal Fetal Medicine with the assistance of Amanda Stone,
UOG Journal Club: July 2013 Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis G. Pagani, F. D’Antonio,
SMFM Clinical Practice Guidelines Risks of chorionic villus sampling and amniocentesis Society of Maternal Fetal Medicine with the assistance of Joanne.
Evidence Based Practice RCS /9/05. Definitions  Rosenthal and Donald (1996) defined evidence-based medicine as a process of turning clinical problems.
SMFM Consult Series Peridontal disease and preterm birth Society of Maternal Fetal Medicine with the assistance of Kim Bogess, MD Published in Contemporary.
SMFM Consult Series Management of cesarean delivery in the morbidly obese woman Society of Maternal Fetal Medicine with the assistance of Donna Johnson,
SMFM Clinical Practice Guidelines
EVIDENCE BASED PRACTICE BY MOHEB KHOUZAM MD. EVIDENCE BASED PRACTICE  1- TYPES OF STUDY DESIGNS  2- RECOMMENDATIONS.
Sifting through the evidence Sarah Fradsham. Types of Evidence Primary Literature Observational studies Case Report Case Series Case Control Study Cohort.
ANTENATAL CARE OF TWIN PREGNANCY
SMFM Clinical Consult Series
EVALUATING u After retrieving the literature, you have to evaluate or critically appraise the evidence for its validity and applicability to your patient.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 17 Clinical Practice Guidelines and Clinical Prediction Rules.
Evidence-Based Practice
Guidelines in Cerebrovascular Neurosurgery Resident Session December 2000.
EVIDENCE-BASED MEDICINE AND PHARMACY 1. Evidence-based medicine 2. Evidence-based pharmacy.
NABEEL BONDAGJI, MD, FRCSC CONSULTANT PERINATOLOGIST KFSH&RC - JEDDAH “CONTRACEPTION IN WOMEN WITH MEDICAL DISORDERS”
EVIDENCE BASED PRACTICE ATHANASIA KOSTOPOULOU ERASMUS IPs
Evidence-Based Mental Health PSYC 377. Structure of the Presentation 1. Describe EBP issues 2. Categorize EBP issues 3. Assess the quality of ‘evidence’
Ghada Aboheimed, Msc. Review the principles of an evidence based approach to clinical practice. Appreciate the value of EBM Describe the 5 steps of evidence.
Stillbirth in twins, exploring the optimal gestational age for delivery: a retrospective cohort study S Wood, S Tang, S Ross, R Sauve.
Vincenzo Berghella, MD; Tracy Manuck, MD
Developing a guideline
The Research Design Continuum
SMFM Clinical Practice Guidelines
Evidence-Based Practice I: Definition – What is it?
Jeffrey A. Kuller, MD; Sean C. Blackwell, MD
UOG Journal Club: December 2017
Perinatal Quality Foundation (
Speeding access to therapies
Society Perspective 07 SEPT 2018
UOG Journal Club: February 2019 systematic review and meta-analysis
Evidence-Based Practice
Evidence-Based Public Health
UOG Journal Club: October 2019
Presentation transcript:

SMFM Clinical Practice Guidelines Twin-twin transfusion syndrome Society of Maternal Fetal Medicine with the assistance Lynn L. Simpson, BSc, MSc, MD Published in Am J Obstet Gynecol / January 2013

Objective We sought to review the natural history, pathophysiology, diagnosis, and treatment options for twin-twin transfusion syndrome (TTTS). The more you interrupt, the better

Recommendation #1 The diagnosis of TTTS requires 2 criteria: (1) the presence of a MCDA pregnancy; and (2) the presence of oligohydramnios (defined as a MVP of 2 cm) in one sac, and of polyhydramnios (a MVP of 8 cm) in the other sac. Quality of Evidence = II and III Strength of Recommendation = Level B

Recommendation #2 The Quintero staging system appears to be a useful tool for describing the severity of TTTS in a standardized fashion. Quality of Evidence = II and III Strength of Recommendation = Level B

Recommendation #3 Serial sonographic evaluations about every 2 weeks, beginning usually around 16 weeks of gestation, until delivery, should be considered for all twins with MCDA placentation. Quality of Evidence = II and III Strength of Recommendation = Level B

Recommendation #4 Screening for congenital heart disease is warranted in all monochorionic twins, in particular those complicated by TTTS. Quality of Evidence = II and III Strength of Recommendation = Level B

Recommendation #5 Extensive counseling should be provided to patients with pregnancies complicated by TTTS including natural history of the disease, as well as management options and their risks and benefits. Over three fourths of stage I TTTS cases remain stable or regress without invasive interventions. The natural history of advanced (e.g., stage III) TTTS is bleak, with a reported perinatal loss rate of 70- 100%, particularly when it presents 26 weeks. The management options available for TTTS include expectant management, amnioreduction, intentional septostomy of the intervening membrane, fetoscopic laser photocoagulation of placental anastomoses, selective reduction, and pregnancy termination. Quality of Evidence = II and III Strength of Recommendation = Level B

Recommendation #6 Patients with stage I TTTS may often be managed expectantly, as the natural history perinatal survival rate is about 86%. Quality of Evidence = II and III Strength of Recommendation = Level B

Recommendation #7 Fetoscopic laser photocoagulation of placental anastomoses is considered by most experts to be the best available approach for stages II, III, and IV TTTS in continuing pregnancies at26 weeks, but the meta analysis data show no significant survival benefit, and the long-term neurologic outcomes in the Eurofetus trial were not different than in non laser-treated controls. Laser treated TTTS is still associated with a 30-50% chance of overall perinatal death and a 5-20% chance of long-term neurologic handicap. Quality of Evidence = I and II Strength of Recommendation = Level B

Recommendation #8 Steroids for fetal maturation should be considered at 24 to 336/7 weeks, particularly in pregnancies complicated by stage III TTTS, and those undergoing invasive interventions. Quality of Evidence = I and II Strength of Recommendation = Level B

Recommendation #9 Optimal timing of delivery for TTTS pregnancies depends on several factors, including disease stage and severity, progression, effect of interventions (if any), and results of antenatal testing. Timing delivery at around 34-36 weeks may be reasonable in selected cases. Quality of Evidence = III Strength of Recommendation = Level C

Staging of twin-twin transfusion syndrome

First- and second-trimester sonographic findings associated with twin-twin transfusion syndrome

Algorithm for management of TTTS

Quality of evidence The quality of evidence for each article was evaluated according to the method outlined by the US Preventative Services Task Force: I Properly powered and conducted randomized controlled trial (RCT); well conducted systematic review or meta-analysis of homogeneous RCTs. II-1 Well-designed controlled trial without randomization. II-2 Well-designed cohort or case-control analytic study. II-3 Multiple time series with or without the intervention; dramatic results from uncontrolled experiment. III Opinions of respected authorities, based on clinical experience; descriptive studies or case reports; reports of expert committees. Brian in particular

Strength of Recommendations Recommendations were graded in the following categories: Level A The recommendation is based on good and consistent scientific evidence. Level B The recommendation is based on limited or inconsistent scientific evidence. Level C The recommendation is based on expert opinion or consensus. Brian in particular

These slides are for personal, non-commercial and educational use only Disclaimer The practice of medicine continues to evolve, and individual circumstances will vary. This opinion reflects information available at the time of its submission for publication and is neither designed nor intended to establish an exclusive standard of perinatal care. This presentation is not expected to reflect the opinions of all members of the Society for Maternal-Fetal Medicine. These slides are for personal, non-commercial and educational use only Brian in particular

Disclosures This opinion was developed by the Publications Committee of the Society for Maternal-Fetal Medicine with the assistance of Lynn L. Simpson, BSc, MSc,. MD, and was approved by the Executive Committee of the Society on September 20, 2012. Dr Simpson, and each member of the Publications Committee (Vincenzo Berghella, MD [Chair], Sean Blackwell, MD [Vice-Chair], Brenna Anderson, MD, Suneet P. Chauhan, MD, Joshua Copel, MD, Jodi Dashe, MD, Cynthia Gyamfi, MD, Donna Johnson, MD, Sara Little, MD, Kate Menard, MD, Mary Norton, MD, George Saade, MD, Neil Silverman, MD, Hyagriv Simhan, MD, Joanne Stone, MD, Alan Tita, MD, PhD, Michael Varner, MD, Ms Deborah Gardner) have submitted a conflict of interest disclosure delineating personal, professional, and/or business interests that might be perceived as a real or potential conflict of interest in relation to this publication. Brian in particular